InnoCare Pharma Limited 諾誠健華醫藥有限公司

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2022, 2020, 2019

In its 2023 reporting, InnoCare Pharma Limited 諾誠健華醫藥有限公司 disclosed greenhouse gas emissions of 12.1K tCO2e/year. By scope: Scope 1: 19.95 tCO2e/year; Scope 2: 12.1K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
12.1K tCO2e/year
2023
💧
Water Usage
135.0K m3/year
2023
♻️
Waste
1.4K tons/year (hazardous and non-hazardous combined)
2023
⚙️
Energy Use
24.1K MWh/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).19.95 tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.12.1K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
202312.1K tCO2e/year
20229.8K tons of CO2 equivalent
20202.6K tonnes CO2e
20192.1K tons of CO2 (indirect emissions from office operations and projects under construction)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

📅 Medium-term

  • Reduce energy use intensity by 10% by 2028 (from 2023 baseline).
  • Reduce industrial wastewater discharge intensity by 10% by 2028 (from 2023 baseline).
  • Reduce greenhouse gas emission intensity by 10% by 2028 (from 2023 baseline).

🌱 ESG Focus Areas

Corporate GovernanceProduct and Service ResponsibilityTalent DevelopmentEnvironmental ProtectionSocial Welfare

⚠️ Challenges & Risks +

  • Operational risks
  • Adverse drug reaction risk
  • Financial risk
  • Credit risk
  • EHS risk
  • Compliance risk
  • Information security risk
  • Climate-related risks (acute physical, chronic physical, policy and regulations, reputational)
  • Non-climate related risks (not explicitly stated, but implied through general risk management discussion)

📋 Report Information

Reporting Period: 2023
Frameworks: HKEX Environmental, Social and Governance Reporting Guide, Guidelines No. 2 for Application of Self-Regulation Rules for Companies Listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange